pimagedine has been researched along with metformin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Audic, N; Ermolenko, L; Franck, G; Garcia-Alvarez, MC; Martin, MT; Nhiri, N; Potier, P; Sasaki, NA; Wang, Q | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Lagarde, M; Lecomte, M; Moinet, G; Patereau, G; Ruggiero-Lopez, D; Wiernsperger, N | 1 |
| Bonnefont-Rousselot, D | 1 |
| Bíró, K; Jednákovits, A; Kukorelli, T; Kürthy, M; Mogyorósi, T; Nagy, K; Tálosi, L | 1 |
| Hirano, K; Kato, M; Kiho, T; Usui, S | 1 |
| Machado, AP; Moysés, ZP; Nakandakare, ER; Passarelli, M; Pinto, RS; Quintão, EC | 1 |
| Beyaz, A; Reddy, VP | 1 |
| Barter, PJ; Brown, BE; Davies, MJ; Nobécourt, E; Rye, KA; Yadav, S; Zeng, J | 1 |
| Imaizumi, T; Matsui, J; Matsuki, K; Murakami, H; Satoh, K; Suda, T; Tamasawa, N; Tanabe, J; Yamashita, M | 1 |
| André, DM; Anhê, GF; Antunes, E; Bordin, S; Calixto, MC; Ferreira, D; Landgraf, RG; Leiria, LO; Lellis-Santos, C; Lintomen, L | 1 |
| Al-Dhalimy, M; Deater, M; Grompe, M; Li, H; Major, A; Marcogliese, AN; Monnat, RJ; Olson, S; Phan, N; Tang, W; Zhang, QS | 1 |
2 review(s) available for pimagedine and metformin
| Article | Year |
|---|---|
[Antioxidant and anti-AGE therapeutics: evaluation and perspectives].
Topics: Antioxidants; Chromans; Diabetes Mellitus; Gliclazide; Glycation End Products, Advanced; Guanidines; Humans; Hypoglycemic Agents; Metformin; Oxidative Stress; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Thiazoles; Thiazolidinediones; Troglitazone | 2001 |
Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases.
Topics: Aging; Animals; Diabetes Mellitus, Type 2; Glycation End Products, Advanced; Guanidines; Humans; Hypoglycemic Agents; Maillard Reaction; Metformin; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2006 |
10 other study(ies) available for pimagedine and metformin
| Article | Year |
|---|---|
N-Terminal 2,3-diaminopropionic acid (Dap) peptides as efficient methylglyoxal scavengers to inhibit advanced glycation endproduct (AGE) formation.
Topics: beta-Alanine; Chromatography, High Pressure Liquid; Electrophoresis, Polyacrylamide Gel; Glycation End Products, Advanced; Magnetic Resonance Spectroscopy; Peptides; Pyruvaldehyde | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation.
Topics: Animals; Azepines; Cattle; Enzyme Inhibitors; Glycation End Products, Advanced; Glycosylation; Glyoxal; Guanidines; Hypoglycemic Agents; Metformin; Pyruvaldehyde; Serum Albumin | 1999 |
Effect of BRX-220 against peripheral neuropathy and insulin resistance in diabetic rat models.
Topics: Animals; Diabetic Neuropathies; Guanidines; Hydroxylamines; Hypoglycemic Agents; Insulin Resistance; Male; Metformin; Pioglitazone; Rats; Rats, Wistar; Rats, Zucker; Streptozocin; Thiazoles; Thiazolidinediones | 2002 |
Effect of buformin and metformin on formation of advanced glycation end products by methylglyoxal.
Topics: Animals; Buformin; Cattle; Enzyme-Linked Immunosorbent Assay; Glycation End Products, Advanced; Guanidines; Metformin; Pyruvaldehyde; Ribonucleases; Serum Albumin, Bovine; Time Factors | 2005 |
Aminoguanidine and metformin prevent the reduced rate of HDL-mediated cell cholesterol efflux induced by formation of advanced glycation end products.
Topics: Albumins; Animals; Atherosclerosis; Cells, Cultured; Cholesterol, HDL; Diabetes Mellitus; Enzyme Inhibitors; Glycation End Products, Advanced; Guanidines; Humans; Hypoglycemic Agents; Lysine; Macrophages, Peritoneal; Metformin; Mice | 2006 |
Effects of cross-link breakers, glycation inhibitors and insulin sensitisers on HDL function and the non-enzymatic glycation of apolipoprotein A-I.
Topics: Apolipoprotein A-I; Arginine; Cross-Linking Reagents; Glycosylation; Guanidines; Humans; Lipoproteins, HDL; Lysine; Metformin; Phosphatidylcholine-Sterol O-Acyltransferase; Pyridoxamine; Pyruvaldehyde; Thiazoles; Tryptophan | 2008 |
Metformin restores impaired HDL-mediated cholesterol efflux due to glycation.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 1; ATP-Binding Cassette Transporters; Cells, Cultured; Cholesterol; Deoxyglucose; Gene Expression; Glycation End Products, Advanced; Glycosylation; Guanidines; Humans; Lipoproteins, HDL; Macrophages; Metformin | 2009 |
Metformin attenuates the exacerbation of the allergic eosinophilic inflammation in high fat-diet-induced obesity in mice.
Topics: AMP-Activated Protein Kinases; Animals; Asthma; Blotting, Western; Bronchoalveolar Lavage Fluid; Diet, High-Fat; Enzyme Inhibitors; Eosinophils; Guanidines; Hypoglycemic Agents; Inflammation; Insulin Resistance; Lung; Male; Metformin; Mice; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase Type II; Obesity; Ovalbumin; Promoter Regions, Genetic; Protein Binding; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2013 |
Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice.
Topics: Aldehydes; Animals; Blood Cell Count; Bone Marrow Cells; Carcinogenesis; Cell Cycle; Chromosome Breakage; Diet; DNA Damage; Fanconi Anemia; Fanconi Anemia Complementation Group D2 Protein; Guanidines; Hematopoiesis; Hematopoietic Stem Cells; Humans; Inactivation, Metabolic; Metformin; Mice; Poly I-C | 2016 |